107 related articles for article (PubMed ID: 26278973)
1. Molecular docking study of natural alkaloids as multi-targeted hedgehog pathway inhibitors in cancer stem cell therapy.
Mayank ; Jaitak V
Comput Biol Chem; 2016 Jun; 62():145-54. PubMed ID: 26278973
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells.
Justilien V; Fields AP
Clin Cancer Res; 2015 Feb; 21(3):505-13. PubMed ID: 25646180
[TBL] [Abstract][Full Text] [Related]
3. Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling.
Lu Y; Ma W; Mao J; Yu X; Hou Z; Fan S; Song B; Wang H; Li J; Kang L; Liu P; Liu Q; Li L
Chem Biol Interact; 2015 Feb; 228():100-7. PubMed ID: 25499043
[TBL] [Abstract][Full Text] [Related]
4. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
5. Targeting GLI factors to inhibit the Hedgehog pathway.
Infante P; Alfonsi R; Botta B; Mori M; Di Marcotullio L
Trends Pharmacol Sci; 2015 Aug; 36(8):547-58. PubMed ID: 26072120
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Modulators as Potential Multi-targeted Drugs Against Hedgehog Pathway for Treatment of Cancer.
Singh AN; Sharma N
Protein J; 2019 Oct; 38(5):537-550. PubMed ID: 30993446
[TBL] [Abstract][Full Text] [Related]
7. Targeting the hedgehog pathway: the development of cyclopamine and the development of anti-cancer drugs targeting the hedgehog pathway.
Gould A; Missailidis S
Mini Rev Med Chem; 2011 Mar; 11(3):200-13. PubMed ID: 21222574
[TBL] [Abstract][Full Text] [Related]
8. Targeting Hedgehog signaling and understanding refractory response to treatment with Hedgehog pathway inhibitors.
Queiroz KC; Spek CA; Peppelenbosch MP
Drug Resist Updat; 2012 Aug; 15(4):211-22. PubMed ID: 22910179
[TBL] [Abstract][Full Text] [Related]
9. MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor.
Hoch L; Faure H; Roudaut H; Schoenfelder A; Mann A; Girard N; Bihannic L; Ayrault O; Petricci E; Taddei M; Rognan D; Ruat M
FASEB J; 2015 May; 29(5):1817-29. PubMed ID: 25636740
[TBL] [Abstract][Full Text] [Related]
10. Targeting Hedgehog--a cancer stem cell pathway.
Merchant AA; Matsui W
Clin Cancer Res; 2010 Jun; 16(12):3130-40. PubMed ID: 20530699
[TBL] [Abstract][Full Text] [Related]
11. Salinomycin induces selective cytotoxicity to MCF-7 mammosphere cells through targeting the Hedgehog signaling pathway.
Fu YZ; Yan YY; He M; Xiao QH; Yao WF; Zhao L; Wu HZ; Yu ZJ; Zhou MY; Lv MT; Zhang SS; Chen JJ; Wei MJ
Oncol Rep; 2016 Feb; 35(2):912-22. PubMed ID: 26718029
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics.
Peukert S; Miller-Moslin K
ChemMedChem; 2010 Apr; 5(4):500-12. PubMed ID: 20229564
[TBL] [Abstract][Full Text] [Related]
13. Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells.
Santini R; Vinci MC; Pandolfi S; Penachioni JY; Montagnani V; Olivito B; Gattai R; Pimpinelli N; Gerlini G; Borgognoni L; Stecca B
Stem Cells; 2012 Sep; 30(9):1808-18. PubMed ID: 22730244
[TBL] [Abstract][Full Text] [Related]
14. Next-Generation Hedgehog/GLI Pathway Inhibitors for Cancer Therapy.
Peer E; Tesanovic S; Aberger F
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30991683
[TBL] [Abstract][Full Text] [Related]
15. Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer.
Xu FG; Ma QY; Wang Z
Cancer Lett; 2009 Oct; 283(2):119-24. PubMed ID: 19232458
[TBL] [Abstract][Full Text] [Related]
16. Nanoquinacrine induced apoptosis in cervical cancer stem cells through the inhibition of hedgehog-GLI1 cascade: Role of GLI-1.
Nayak A; Satapathy SR; Das D; Siddharth S; Tripathi N; Bharatam PV; Kundu C
Sci Rep; 2016 Feb; 6():20600. PubMed ID: 26846872
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic.
Laranjeira AB; Yang SX
Expert Opin Drug Discov; 2016 Nov; 11(11):1071-1080. PubMed ID: 27626707
[TBL] [Abstract][Full Text] [Related]
18. New approaches to target cancer stem cells: current scenario.
Insan MB; Jaitak V
Mini Rev Med Chem; 2014 Jan; 14(1):20-34. PubMed ID: 24195662
[TBL] [Abstract][Full Text] [Related]
19. [Cancer Stem Cells (CSCs) as a Rational Therapeutic Cancer Target, and Screening for CSC-targeting Drugs].
Mashima T
Yakugaku Zasshi; 2017; 137(2):129-132. PubMed ID: 28154319
[TBL] [Abstract][Full Text] [Related]
20. Digging a hole under Hedgehog: downstream inhibition as an emerging anticancer strategy.
Di Magno L; Coni S; Di Marcotullio L; Canettieri G
Biochim Biophys Acta; 2015 Aug; 1856(1):62-72. PubMed ID: 26080084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
